PMDA

shutterstock_552100717

Japan renews its participation in MDSAP until 2020

By Luis Jimenez | 2 May 2019
Japan’s participation in MDSAP (Medical Device Standardized Audit Program) has been a contributing factor in the exponential update of MDSAP by multinational companies. Japan’s MHLW and PMDA has been opting...
Brandwood Biomedical global experts medical devices regulatory affairs consulting medical devices IVDs Brandwood Biomedical Global Expertise in Medical Device Regulatory Compliance Australia China Taiwan Hong Kong Europe New Zealand United States

Australia via 510(k): TGA – recognises US, Canadian and Japanese approvals with MDSAP

By Arthur Brandwood | 30 August 2018
Australia’s regulatory system is modelled very closely on that of Europe. This equivalence of requirements and assessment pathways has allowed TGA to leverage prior CE marking to grant Australian device...

Search

Recent Posts

Provisionally yours

Jan 27, 2021

Clinical Evidence Insights for Medical Devices in China

Jan 22, 2021

EUDAMED is LIVE

Dec 15, 2020

MD Regulatory transition under Brexit

Dec 15, 2020

DOC’s will need to be submitted for new Class I IVD ARTG registrations

Nov 26, 2020

Formulated ingredients and premixes: Keeping the IP of a PI

Nov 24, 2020

Categories

Categories

Archives

Archives

Archives

Tags

510(k) ARTG Australia Biocompatibility Brexit CE CE Certificates China clinical evidence clinical trials Conformity Assessment coronavirus COVID-19 COVID19 de novo Drug EU Europe FDA guidance IVD IVDD IVDR IVDs MDD MDR MDSAP medical device Medical Device Regulations medical devices Medicine medicines MHRA Pharmaceutical PMA PMDA postmarket Reform regulatory Reimbursement SaMD Software Software as a Medical Device (SaMD) standards TGA